RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $117,000 | -43.2% | 21,264 | 0.0% | 0.00% | – |
| Q4 2021 | $206,000 | -44.2% | 21,264 | +3.0% | 0.00% | -100.0% |
| Q3 2021 | $369,000 | -26.8% | 20,645 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $504,000 | +28.2% | 20,645 | +39.1% | 0.00% | 0.0% |
| Q1 2021 | $393,000 | +257.3% | 14,845 | +2.2% | 0.00% | – |
| Q4 2020 | $110,000 | +50.7% | 14,525 | 0.0% | 0.00% | – |
| Q3 2020 | $73,000 | -16.1% | 14,525 | 0.0% | 0.00% | – |
| Q2 2020 | $87,000 | – | 14,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |